NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, SOUTH AFRICA OR ANY OTHER STATE OR JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (596/2014/EU). ART SHARE 002 S.A.16, rue E. Ruppert, L-2453 LuxembourgGrand Duchy of LuxembourgR.C.S.L: B273672ARTEX Global Mar ...

Broadridge Financial Solutions Conference Summary Company Overview - Broadridge Financial Solutions is a leading provider of technology infrastructure in the financial services industry with a market cap of approximately $28 billion and annual fee revenue of $4.5 billion [3][4] - The company serves clients primarily in wealth management, asset management, capital markets, and corporate issuers, including 28 of the 29 globally systemic important banks [4] Core Business Segments - The Investor Communication Solutions (ICS) unit connects corporate issuers to investors through banks and advisors, facilitating a unique network [5] - The Global Technology Operations (GTO) business includes capital markets and wealth management services, providing front, middle, and back office systems [6][7] Growth Plans - Broadridge's growth strategy focuses on three areas: governance franchise, capital markets, and wealth management modernization [8][9] - The governance franchise aims to democratize and digitize governance, with mid-teens position growth in equities and mid-single digits in funds for FY25 [11][12] - Capital markets are being simplified and innovated, with a focus on AI and new technologies like Bond GPT [13][14] - Wealth management is being modernized through modular solutions, allowing firms to upgrade their back office capabilities [15] Financial Performance - Over the last decade, Broadridge has achieved 10% recurring revenue growth and 13% adjusted EPS growth, with dividends growing in line with earnings [16][17] - The company targets 5-8% organic revenue growth and 8-12% EPS growth over the next three years [17] Market Trends - The democratization of investing is driving position growth, with more investors entering the market and increasing the number of positions per investor [22][23] - Position growth has been in the high single digits over the last decade, with expectations for continued positive trends [25][26] Digital Transformation - Broadridge is actively investing in digital communications, with 85-90% of regulatory communications already suppressed digitally [32] - The customer communications business, valued at $700 million, is transitioning from 85% print to a growing digital segment [38][40] Revenue Streams - Recurring revenue is defined as revenue under contract for multiple years, while event-driven revenue is one-time or sporadic [46][47] - Distribution revenue, primarily from physical output, is expected to grow in the medium term but will likely dissipate in the long term as digital strategies are executed [50][51] Demand and Market Conditions - Demand for solutions related to cost efficiency remains strong, with clients seeking to reduce operational costs [55] - Market volatility has historically not negatively impacted position growth, with strong defensibility observed since 2007 [59][61] Competitive Landscape - Broadridge holds a significant share in the proxy business, with competitors like Proxy Trust and Mediant [66] - The company is exploring growth opportunities in the global proxy business as international investors increasingly buy US securities [66] Regulatory Environment - Current regulations, including potential digital asset disclosures and proxy reforms, are seen as opportunities for Broadridge [68][69] - The company has developed a disclosure solution for digital assets called Clarify [68] Capital Allocation Strategy - Broadridge prioritizes internal growth investments, dividends, tuck-in M&A opportunities, and share buybacks while maintaining an investment-grade credit rating [75][76]

Core Insights - MBX Biosciences, Inc. is focused on developing novel precision peptide therapies for endocrine and metabolic disorders, with a significant emphasis on post-bariatric hypoglycemia (PBH) treatment [1][6] - The company will present findings on MBX 1416 at the American Diabetes Association's 85th Scientific Sessions, highlighting its potential as a once-weekly treatment for PBH [2][1] - MBX 1416 has shown positive results in Phase 1 clinical trials, with a Phase 2 trial expected to start in the latter half of 2025 [2] Company Overview - MBX Biosciences is based in Carmel, Indiana, and utilizes its proprietary PEP™ platform to develop therapies targeting endocrine and metabolic disorders [6] - The company's pipeline includes MBX 2109 for chronic hypoparathyroidism in Phase 2, MBX 1416 for PBH in Phase 1, and an obesity portfolio with an IND filing anticipated in Q2 2025 [6] Product Details - MBX 1416 is an investigational long-acting GLP-1 receptor antagonist designed to prevent severe hypoglycemia in individuals with PBH [4] - PBH is a serious complication following bariatric surgery, characterized by recurrent hypoglycemic episodes, and currently lacks approved pharmacotherapies [5] Upcoming Presentations - Presentations on MBX 1416 will take place on June 22, 2025, during the General Poster Session at the ADA conference, featuring studies on its safety, pharmacokinetics, and effects on blood glucose levels [7]

Welcome to the beat. I'm Ari Melbour and we are covering the late breaking news out of Los Angeles. Late today, the latest development in a clash that seems escalated by the federal government under the Trump administration includes now a small number of US Marines formally mobilized to respond to this ongoing clash and the protests.Today's protests, and you can see some of the footage and we've been tracking this, are overwhelmingly peaceful across the city there. The escalation though has little precedent ...

When my father took over. At that time, the big fracture was upstate versus downstate. Yes.I lived it. Yes, We loved it. And upstate for non-New Yorkers, primarily Republican leaning conservative New York City at that time, very, very liberal.So that was the big divide. Now, it's basically within New York City and it's really within the Democratic Party. I mean, we have the Democratic-Republican schism, obviously, in New York City, but the Republican Party is relatively small in New York City.But we are wor ...

Summary of Crinetics Pharmaceuticals (CRNX) Conference Call Company Overview - **Company**: Crinetics Pharmaceuticals (CRNX) - **Event**: Jefferies Healthcare Conference, June 5, 2025 - **Key Speaker**: CEO Scott Struthers Core Points and Arguments Product Pipeline and Milestones - Crinetics is preparing for a PDUFA date on September 25 for its first molecule, paltusotine, aimed at treating acromegaly [2][3] - The company has a robust pipeline, including a second drug, Atumelnat, targeting congenital adrenal hyperplasia and Cushing's disease [3][4] - Crinetics has developed all its drugs in-house, with the exception of licensing paltusotine rights in Japan and a technology platform to Radionetics [4][6] Financial Position - The company is in a strong financial position with $1 billion in the bank, sufficient to last until 2029 without partnerships [6] Market Dynamics for Acromegaly - The acromegaly market has approximately 11,000 addressable patients, with segments for new therapies, switching from existing treatments, and re-engaging lost patients [13][15] - There is a significant unmet need, with 20% of patients requiring more frequent injections than the standard regimen [14] - Approximately 80% of patients discontinue treatment within three years, indicating a potential market for re-engagement [15][16] Sales and Marketing Strategy - The company is onboarding its sales team and engaging with key opinion leaders (KOLs) to improve patient care and drug delivery [9][10][18] - Crinetics aims to educate physicians on treatment guidelines and the importance of managing acromegaly effectively [25][26] Payer Engagement and Pricing Strategy - Crinetics has been actively engaging with payers, receiving positive feedback regarding the drug's efficacy and the cost savings associated with reducing wastage from current injectable therapies [32][33] - The company is still evaluating its pricing strategy based on value and market research [38] Future Outlook - The company anticipates a lag in revenue realization post-launch due to formulary updates and patient visits [40] - Crinetics is preparing for Phase III trials for Atumelnat, with a focus on rethinking treatment paradigms for congenital adrenal hyperplasia [42][44] Additional Important Content - The company emphasizes the importance of improving healthcare delivery for acromegaly patients, not just providing a new drug [10][12] - There is a focus on patient education and support services to enhance treatment adherence and outcomes [21][22] - The company has a diverse pipeline with multiple ongoing programs, indicating a long-term growth strategy [54]

Key Takeaways Robinhood is eligible for inclusion in the index with a $63B market cap and four straight profitable quarters. A 94% YTD stock surge reflects HOOD's product expansion, acquisitions, and crypto market momentum. The entry into the index could boost HOOD's visibility and demand, despite regulatory and market headwinds.Robinhood Markets Inc. (HOOD) is poised for potential inclusion in the S&P 500 Index, with an official announcement expected tomorrow. The index’s quarterly rebalancing occurs lat ...

Core Insights - Robinhood Markets Inc. has significantly democratized access to financial markets for retail investors, leading to increased popularity and adoption of its platform [1] - The company continues to explore growth opportunities by expanding its services, including retirement account management and high-yield savings features [2][6] - Robinhood's stock has experienced a substantial rally of 92% over the past six months, driven by its growing market share and financial performance [4][6] Company Performance - Robinhood's user base has grown by 1.9 million over the past year, reaching a total of 25.8 million users [10] - The company reported net assets under custody of $221 billion, reflecting a 70% increase compared to the first quarter of 2024 [11] - Total revenues for Robinhood reached $927 million, or $3.3 billion over a 12-month period, showcasing the high margins typical of its software-based business model [12] Market Activity - Trading volume on Robinhood's platform reached $413 billion for equities and $500 million for stock options in the first quarter of 2025 [13] - Increased trading activity has been attributed to market volatility caused by recent trade tariffs, which is expected to positively impact earnings per share (EPS) moving forward [14] Strategic Developments - Robinhood has completed the acquisition of cryptocurrency exchange Bitstamp for $200 million, enhancing its capabilities in the cryptocurrency market [7] - The potential addition of Robinhood to the S&P 500 index has generated interest, although it remains uncertain [3][5]

Realty Income (O) 2025 Conference Summary Company Overview - **Company**: Realty Income Corporation (Ticker: O) - **Industry**: Real Estate Investment Trust (REIT), specifically focused on net lease properties Key Points and Arguments Business Model and Performance - Realty Income's platform is designed to deliver durable income and growth, which is particularly valuable in a dynamic capital market environment with persistent inflation [3][4] - The company has achieved an average total operational return of 11% over the past 30 years, with a minimum annual return of 5% [4] - The business model focuses on predictable cash flows and flexibility in investment allocation across various geographies and sectors [4][6] Investment Strategy - In Q1, Realty Income deployed $1.4 billion in investments, with 65% of this volume coming from Europe [5][11] - The portfolio is diversified, with 65% of global assets in U.S. retail, which includes high-quality tenants [5][6] - The company has expanded its investment capabilities beyond traditional sale-leasebacks to include development funding and credit investments [10][11] European Market Focus - Realty Income has significantly increased its investments in the UK, growing from zero in 2019 to $10 billion today [15][16] - The company sees Europe as a fertile ground for growth, with current investments in Europe totaling approximately $2 billion [16] Sector Diversification - Realty Income is not limited to retail; it has investments in industrial, data centers, and gaming sectors [8][10] - The company is particularly interested in data centers due to the demand from hyperscalers for long-term leases [19][20] Tenant Credit and Bad Debt Management - The company has constructed its retail portfolio to withstand potential tariff impacts, with bad debt expenses averaging 40 basis points [24][25] - Recent exposures to tenants like At Home, Zips, and Party City have been nominal, with Zips already resolved through bankruptcy [26][27] Private Capital Initiative - Realty Income is moving into private capital to complement its public shareholder base, aiming to raise $4.5 billion in 2025 [31][34] - The private capital initiative is seen as a way to access additional sources of capital, especially during market disruptions [32][34] Valuation and Market Position - Realty Income is currently trading below historical valuation multiples despite its consistent performance, which is expected to lead to a rerating over time [35][36] - The company aims to attract income-oriented investors, particularly in Europe, where there is a significant demand for dependable income streams [37][51] Dividend Policy - Realty Income has a payout ratio in the mid-70s and has consistently increased dividends for over 30 years, establishing itself as a "dividend aristocrat" [41][43] - The company emphasizes the importance of maintaining dividend growth without over-leveraging [45][46] Additional Important Insights - The company utilizes predictive analytics to enhance decision-making across its operations, improving lease negotiations and asset management [12][13] - Realty Income's strong balance sheet and credit rating (A- and A3) support its investment strategy and dividend policy [45][46] - The company is focused on building strong relationships with tenants to ensure operational success and sustainability [48][49]

Core Viewpoint - The Trump administration's decision to allow Chevron to maintain its assets in Venezuela is seen as a positive move by Republican Congressman Carlos Gimenez, who supports a return to Trump-era policies regarding Venezuela and its regime under Nicolás Maduro [1][6][15]. Group 1: Chevron's Operations in Venezuela - Chevron is permitted to maintain its assets in Venezuela but is restricted from importing oil and paying royalties to the Maduro regime, which could amount to over $700 million monthly [5][9][15]. - The concern exists that if Chevron were forced out, Chinese interests might take over its assets, which are considered superior in quality compared to other Venezuelan oil infrastructure [5][9]. Group 2: Political Context and Implications - Gimenez emphasizes the intertwined economic relationship between Maduro and Cuban leader Miguel Diaz-Canel, with Venezuela supplying oil to Cuba in exchange for security personnel [11][12]. - The Congressman advocates for a peaceful transition to a legitimate government in Venezuela, supporting Edmundo Gonzalez, who was declared to have lost the 2024 election under disputed circumstances [13][15]. Group 3: Broader Implications for U.S. Policy - The current situation is framed as a struggle between democracy and dictatorship, with Gimenez urging U.S. interests to remain aligned with democratic principles and to avoid any financial support to the Maduro regime [9][15]. - The article highlights the importance of U.S. policy in supporting democratic movements in Latin America, particularly in Venezuela and Cuba, where strongman regimes are in power [10][15].